These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 34831438)
1. On the Role of the Immunoproteasome in Protein Homeostasis. Basler M; Groettrup M Cells; 2021 Nov; 10(11):. PubMed ID: 34831438 [TBL] [Abstract][Full Text] [Related]
2. HIV-1 Nef Interacts with LMP7 To Attenuate Immunoproteasome Formation and Major Histocompatibility Complex Class I Antigen Presentation. Yang Y; Liu W; Hu D; Su R; Ji M; Huang Y; Shereen MA; Xu X; Luo Z; Zhang Q; Liu F; Wu K; Liu Y; Wu J mBio; 2020 Oct; 11(5):. PubMed ID: 33109760 [TBL] [Abstract][Full Text] [Related]
3. Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity. Basler M; Lindstrom MM; LaStant JJ; Bradshaw JM; Owens TD; Schmidt C; Maurits E; Tsu C; Overkleeft HS; Kirk CJ; Langrish CL; Groettrup M EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30279279 [TBL] [Abstract][Full Text] [Related]
4. The 20S immunoproteasome and constitutive proteasome bind with the same affinity to PA28αβ and equally degrade FAT10. Schmidtke G; Schregle R; Alvarez G; Huber EM; Groettrup M Mol Immunol; 2019 Sep; 113():22-30. PubMed ID: 29208314 [TBL] [Abstract][Full Text] [Related]
5. The Immunoproteasome Subunits LMP2, LMP7 and MECL-1 Are Crucial Along the Induction of Cerebral Toxoplasmosis. French T; Israel N; Düsedau HP; Tersteegen A; Steffen J; Cammann C; Topfstedt E; Dieterich D; Schüler T; Seifert U; Dunay IR Front Immunol; 2021; 12():619465. PubMed ID: 33968021 [TBL] [Abstract][Full Text] [Related]
6. Immunoproteasome Inhibition Selectively Kills Human CD14 Basler M; Claus M; Klawitter M; Goebel H; Groettrup M J Immunol; 2019 Oct; 203(7):1776-1785. PubMed ID: 31484727 [TBL] [Abstract][Full Text] [Related]
7. Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome. Basler M; Maurits E; de Bruin G; Koerner J; Overkleeft HS; Groettrup M Br J Pharmacol; 2018 Jan; 175(1):38-52. PubMed ID: 29034459 [TBL] [Abstract][Full Text] [Related]
8. The immunoproteasome in antigen processing and other immunological functions. Basler M; Kirk CJ; Groettrup M Curr Opin Immunol; 2013 Feb; 25(1):74-80. PubMed ID: 23219269 [TBL] [Abstract][Full Text] [Related]
9. The antiviral immune response in mice devoid of immunoproteasome activity. Basler M; Beck U; Kirk CJ; Groettrup M J Immunol; 2011 Dec; 187(11):5548-57. PubMed ID: 22013127 [TBL] [Abstract][Full Text] [Related]
10. Impairment of immunoproteasome function by β5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. Opitz E; Koch A; Klingel K; Schmidt F; Prokop S; Rahnefeld A; Sauter M; Heppner FL; Völker U; Kandolf R; Kuckelkorn U; Stangl K; Krüger E; Kloetzel PM; Voigt A PLoS Pathog; 2011 Sep; 7(9):e1002233. PubMed ID: 21909276 [TBL] [Abstract][Full Text] [Related]
11. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies. Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114 [TBL] [Abstract][Full Text] [Related]
12. Immunoproteasome-specific inhibitors and their application. Basler M; Groettrup M Methods Mol Biol; 2012; 832():391-401. PubMed ID: 22350900 [TBL] [Abstract][Full Text] [Related]
13. Efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins. Abi Habib J; De Plaen E; Stroobant V; Zivkovic D; Bousquet MP; Guillaume B; Wahni K; Messens J; Busse A; Vigneron N; Van den Eynde BJ Sci Rep; 2020 Sep; 10(1):15765. PubMed ID: 32978409 [TBL] [Abstract][Full Text] [Related]
14. Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i). Scheffler S; Kuckelkorn U; Egerer K; Dörner T; Reiter K; Soza A; Burmester GR; Feist E Rheumatology (Oxford); 2008 May; 47(5):622-6. PubMed ID: 18375405 [TBL] [Abstract][Full Text] [Related]
15. Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. Ettari R; Zappalà M; Grasso S; Musolino C; Innao V; Allegra A Pharmacol Ther; 2018 Feb; 182():176-192. PubMed ID: 28911826 [TBL] [Abstract][Full Text] [Related]
16. The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer. Tripathi SC; Vedpathak D; Ostrin EJ Cells; 2021 Dec; 10(12):. PubMed ID: 34944095 [TBL] [Abstract][Full Text] [Related]
17. Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Guillaume B; Chapiro J; Stroobant V; Colau D; Van Holle B; Parvizi G; Bousquet-Dubouch MP; Théate I; Parmentier N; Van den Eynde BJ Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18599-604. PubMed ID: 20937868 [TBL] [Abstract][Full Text] [Related]
18. Emerging roles of immunoproteasomes beyond MHC class I antigen processing. Ebstein F; Kloetzel PM; Krüger E; Seifert U Cell Mol Life Sci; 2012 Aug; 69(15):2543-58. PubMed ID: 22382925 [TBL] [Abstract][Full Text] [Related]
19. Functional Differences between Proteasome Subtypes. Abi Habib J; Lesenfants J; Vigneron N; Van den Eynde BJ Cells; 2022 Jan; 11(3):. PubMed ID: 35159231 [TBL] [Abstract][Full Text] [Related]
20. The proteasome system in infection: impact of β5 and LMP7 on composition, maturation and quantity of active proteasome complexes. Joeris T; Schmidt N; Ermert D; Krienke P; Visekruna A; Kuckelkorn U; Kaufmann SH; Steinhoff U PLoS One; 2012; 7(6):e39827. PubMed ID: 22768135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]